Understand the source comparison
DSIP Daily Administration: Research Protocol Comparison
Understanding how daily DSIP protocols differ across research models clarifies when continuous administration serves your objectives versus when intermittent dosing is more appropriate. Sleep Architecture Study 50–100mcg SC Daily, 30 min pre-sleep 7–14 days De
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Understanding how daily DSIP protocols differ across research models clarifies when continuous administration serves your objectives versus when intermittent dosing is more appropriate.
- Sleep Architecture Study
- 50–100mcg SC
- Daily, 30 min pre-sleep
- 7–14 days
- Delta wave amplitude, sleep latency, total slow-wave time
- Daily dosing produces cumulative improvement in delta wave metrics without tolerance. Optimal for sleep studies
- Stress Response Model
- 150–300mcg SC or IV
- Every 3–4 days, timed to stressor exposure
- 2–4 weeks total
- Cortisol suppression, HPA axis reactivity, subjective stress markers
- Intermittent high-dose protocol captures acute stress modulation better than daily low-dose. No need for daily administration
- Neuroprotection Study
- 100–150mcg SC
- Daily for 10–21 consecutive days
- Up to 3 weeks
- Oxidative stress markers, neuroinflammatory cytokines, cognitive task performance
- Daily moderate-dose protocol maintains baseline neuroprotective effects; receptor sensitivity does not decline
- Growth Hormone Evaluation
- 100mcg SC
- Daily, administered at circadian GH nadir (late evening)
- 10–14 days
- Nocturnal GH pulse frequency, IGF-1 levels
- Daily dosing produces modest GH increases secondary to cortisol suppression. Not comparable to direct secretagogues like Ipamorelin